Trials / Conditions / Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA

Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA

5 registered clinical trials studyying Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA.

Status	Trial	Sponsor	Phase
Completed	Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia NCT01132586	National Cancer Institute (NCI)	Phase 1
Completed	Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonoc NCT00313586	National Cancer Institute (NCI)	Phase 2
Completed	Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases NCT00351975	National Cancer Institute (NCI)	Phase 1
Completed	Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blast NCT00217646	National Cancer Institute (NCI)	Phase 1
Completed	Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease i NCT00105001	Fred Hutchinson Cancer Center	Phase 2